The Globe and Mail reports in its Wednesday, March 27, edition that a fraud charge against the former chairman and chief executive officer of Instadose Pharma has been stayed in Ontario court over excessive delays, marking another blow to the Ontario Securities Commission's enforcement branch. The Globe's Roy Doolittle writes that Justice Jennifer McAleer made the decision earlier this month, after concluding that Grant Sanders's Charter right to a timely trial had been violated. It has been more than 2-1/2 years since the OSC laid a quasi-criminal charge against Mr. Sanders over allegations he had used money from investors in the cannabis company for his own purposes, and for the benefit of his family and associates. His 20-day trial was supposed to start this week. After removing delays attributable to the defence, Justice McAleer found that 771 days had passed -- more than 25 months -- a violation of the 18-month ceiling that the Supreme Court established for provincial cases in its landmark ruling R. v Jordan. Defence lawyer Scott Fenton, who represented Mr. Sanders, said the OSC should never have brought the case against his client in the first place. He said, "The original investigation was flawed."